Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Vincerx Pharma Inc (VINC)
NASDAQ:VINC
RESEARCH TOOLSreports
Holding VINC?
Track your performance easily
VINC Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.57 - $9.37
Previous Close$0.69
Volume162.09K
Average Volume (3M)305.40K
Market Cap
$20.56M
Enterprise Value$17.67M
Total Cash (Recent Filing)$5.11M
Total Debt (Recent Filing)$2.22M
Price to Earnings (P/E)―
Beta0.91
Next Earnings
Aug 08, 2024EPS Estimate
-$0.21Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.79
Shares Outstanding29,534,238
10 Day Avg. Volume171,333
30 Day Avg. Volume305,396
Standard Deviation0.40
R-Squared0.02
Alpha-0.00293
Financial Highlights & Ratios
Price to Book (P/B)-30.00
Price to Sales (P/S)29.53
Price to Cash Flow (P/CF)-0.60
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue>-0.01
Enterprise Value/Gross Profit29.44
Enterprise Value/Ebitda-0.67
Forecast
1Y Price Target
$4.00Price Target Upside472.82% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
Vincerx Pharma Inc News
PremiumCompany Announcements
Vincerx Pharma Reports Q3 2024 Financial Results
PremiumPre-Earnings
Is VINC a Buy, Before Earnings?
PremiumCompany Announcements
Vincerx Pharma Announces Stock Option Repricing and Shareholder Approval
Ownership Overview
22.93% Insiders
2.54% Mutual Funds
2.10% Other Institutional Investors
72.44% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
VINC FAQ
What was Vincerx Pharma Inc’s price range in the past 12 months?
Vincerx Pharma Inc lowest stock price was $0.57 and its highest was $9.37 in the past 12 months.
What is Vincerx Pharma Inc’s market cap?
Currently, no data Available
When is Vincerx Pharma Inc’s upcoming earnings report date?
Vincerx Pharma Inc’s upcoming earnings report date is Aug 08, 2024 which is 110 days ago.
How were Vincerx Pharma Inc’s earnings last quarter?
Vincerx Pharma Inc released its earnings results on May 14, 2024. The company reported -$0.58 earnings per share for the quarter, missing the consensus estimate of -$0.235 by -$0.345.
Is Vincerx Pharma Inc overvalued?
According to Wall Street analysts Vincerx Pharma Inc’s price is currently Undervalued.
Does Vincerx Pharma Inc pay dividends?
Vincerx Pharma Inc does not currently pay dividends.
What is Vincerx Pharma Inc’s EPS estimate?
Vincerx Pharma Inc’s EPS estimate is -$0.21.
How many shares outstanding does Vincerx Pharma Inc have?
Vincerx Pharma Inc has 29,671,904 shares outstanding.
What happened to Vincerx Pharma Inc’s price movement after its last earnings report?
Vincerx Pharma Inc reported an EPS of -$0.58 in its last earnings report, missing expectations of -$0.235. Following the earnings report the stock price went down -1.316%.
Which hedge fund is a major shareholder of Vincerx Pharma Inc?
Among the largest hedge funds holding Vincerx Pharma Inc’s share is Woodline Partners LP. It holds Vincerx Pharma Inc’s shares valued at 120K.
---
Vincerx Pharma Inc Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$4.00 (472.82% Upside)
$4.00 (472.82% Upside)
Hedge Fund Trend
Increased
By 23.6K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.7%
Last 30 Days ▼ 1.5%
Last 30 Days ▼ 1.5%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-44.64%
12-Months-Change
Fundamentals
Return on Equity
-226.01%
Trailing 12-Months
Asset Growth
-76.64%
Trailing 12-Months
Company Description
Vincerx Pharma Inc
LifeSci Acquisition Corp is a blank check company.
---
VINC Stock 12 Month Forecast
Average Price Target
$4.00
▲(472.82% Upside)
Technical Analysis
BioNTech SE
―
Crinetics Pharmaceuticals
―
Fate Therapeutics
―
Apellis Pharmaceuticals
―
Best Analysts Covering VINC
1 Year
1 Year Success Rate
2/16 ratings generated profit
1 Year Average Return
-15.30%
reiterated a buy rating 7 months ago
Copying Jonathan Chang's trades and holding each position for 1 Year would result in 12.50% of your transactions generating a profit, with an average return of -15.30% per trade.
---